Alpha Tau Medical Ltd. DRTS
13.90 USD +0.36 (+2.66%)
Nov 4, 2026, 12:37 PM EST
13.59 Day range 14.12
3.43 52-week range 15.79
- YTD
- +180.81%
- 1 year
- +259.17%
Financial health
Altman Z-Score
5.26 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -9.3×
FY 2019 5y median -7.2× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 5.2×
FY 2019 5y median 2.5× FY 2025
P/FCF -12.2×
FY 2019 5y median -9.8× FY 2025
EV/EBITDA -9.7×
FY 2019 5y median -7.5× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -8.2%
FY 2019 5y median -10.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -55.3%
FY 2019 5y median -34.5% FY 2025
ROIC -43.5%
FY 2019 5y median -36.5% FY 2025
ROA -40.0%
FY 2019 5y median -36.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -17.3%
FY 2019 FY 2025
EPS (diluted) -17.8%
FY 2019 FY 2025
Free Cash Flow -48.7%
FY 2019 FY 2025
Financial Health
Current Ratio 7.5×
FY 2019 5y median 7.5× FY 2025
Quick Ratio 7.5×
FY 2019 5y median 9.3× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 0.1×
FY 2019 5y median 0.0× FY 2025
Interest Coverage -101×
FY 2019 5y median -101× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31